XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2023   99,895,473          
Beginning balance at Dec. 31, 2023 $ 589,609 $ 100 $ (98,258) $ 906,153 $ (239,729)   $ 21,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (20,675)       (22,628)   1,953
Other comprehensive income 0            
Contributions from noncontrolling interests in subsidiaries 15,250           15,250
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)   0          
Change in ownership percentage in subsidiary 0 $ 0   158     (158)
Stock options exercised (in shares)   61,667          
Stock options exercised 223     223      
Issuance of common stock for vesting of restricted stock units (in shares)   643,182          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   (2,802)          
Shares withheld related to net share settlement of share-based awards (in shares)   (222,061)          
Shares withheld related to net share settlement of share-based awards (1,068)     (1,068)      
Compensation expense for share-based awards 2,530     2,530      
Ending balance (in shares) at Sep. 30, 2024   98,838,337          
Ending balance at Sep. 30, 2024 578,566 $ 99 (105,560) 907,996 (262,357)   38,388
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchase of common stock (in shares)   (1,537,122)          
Repurchase of common stock (7,303) $ (1) (7,302)        
Beginning balance (in shares) at Jun. 30, 2024   100,375,459          
Beginning balance at Jun. 30, 2024 596,745 $ 100 (98,258) 907,215 (248,361)   36,049
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (11,657)       (13,996)   2,339
Other comprehensive income 0            
Compensation expense for share-based awards 781     781      
Ending balance (in shares) at Sep. 30, 2024   98,838,337          
Ending balance at Sep. 30, 2024 578,566 $ 99 (105,560) 907,996 (262,357)   38,388
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchase of common stock (in shares)   (1,537,122)          
Repurchase of common stock (7,303) $ (1) (7,302)        
Beginning balance (in shares) at Dec. 31, 2024   96,048,999          
Beginning balance at Dec. 31, 2024 552,619 $ 96 (118,542) 910,237 (275,786) $ (1,180) 37,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries 19,697       18,264   1,433
Other comprehensive income 1,411         1,411  
Stock options exercised (in shares)   8,333          
Stock options exercised 30     30      
Issuance of common stock for vesting of restricted stock units (in shares)   521,041          
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   56,162          
Shares withheld related to net share settlement of share-based awards (in shares)   (174,157)          
Shares withheld related to net share settlement of share-based awards (670)     (670)      
Compensation expense for share-based awards 3,751     3,751      
Ending balance (in shares) at Sep. 30, 2025   96,460,378          
Ending balance at Sep. 30, 2025 576,838 $ 96 (118,542) 913,348 (257,522) 231 39,227
Beginning balance (in shares) at Jun. 30, 2025   96,444,993          
Beginning balance at Jun. 30, 2025 577,471 $ 96 (118,542) 911,473 (254,792) 345 38,891
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income including noncontrolling interests in subsidiaries (2,394)       (2,730)   336
Other comprehensive income (114)         (114)  
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)   15,385          
Compensation expense for share-based awards 1,875     1,875      
Ending balance (in shares) at Sep. 30, 2025   96,460,378          
Ending balance at Sep. 30, 2025 $ 576,838 $ 96 $ (118,542) $ 913,348 $ (257,522) $ 231 $ 39,227